Agf Investments LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Agf Investments LLC
- $1.09 Billion
- Q3 2022
A detailed history of Agf Investments LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Agf Investments LLC holds 11,560 shares of BHVN stock, worth $401,247. This represents 0.16% of its overall portfolio holdings.
Number of Shares
11,560
Previous 6,651
73.81%
Holding current value
$401,247
Previous $969,000
80.39%
% of portfolio
0.16%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding BHVN
# of Institutions
10Shares Held
565KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL490KShares$17 Million16.74% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$1.25 Million0.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$658,7953.79% of portfolio
-
Birchview Capital, LP Burlington, VT7.37KShares$255,6390.35% of portfolio
-
Surevest, LLC Los Angeles, CA751Shares$26,0670.03% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $2.49B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...